Tytla M E, Trope G E, Buncic J R
Department of Ophthalmology, University of Toronto.
Ophthalmology. 1990 Jan;97(1):36-43. doi: 10.1016/s0161-6420(90)32630-1.
Reductions in flicker sensitivity in ocular hypertension are thought to precede manifest glaucomatous damage, but the proportion of patients with ocular hypertension reported to have losses in flicker sensitivity (50-90%) is far out of step with the proportion of ocular hypertensive patients in whom clinically defined glaucoma will develop (5-30%). The authors examined the possibility that the flicker losses in some of these patients represent not early glaucomatous damage, but instead a transient influence of raised intraocular pressure (IOP) on an otherwise normal eye. Temporal contrast sensitivity was measured in 26 patients with ocular hypertension and in 22 patients with primary open-angle glaucoma (POAG) before and after hypotensive treatment (timolol). Compared with normotensive controls, all POAG patients exhibited sensitivity losses before treatment which remained unchanged after treatment. The ocular hypertensive patients were divided into three groups, which may reflect differing risks of glaucoma conversion. Group I patients (8/26) had normal flicker sensitivity, and thus appear to be resistant to high IOP. Group II patients (9/26) showed initial losses which disappeared with lowered IOP. They probably have not yet suffered damage but appear to be sensitive to high IOP. Group III patients (9/26) had losses that persisted despite lowered IOPs. The similarity of their response to that of the POAGs suggests that group III patients have already suffered early glaucomatous damage.
高眼压症患者的闪烁光敏感度降低被认为先于明显的青光眼性损害,但据报道有闪烁光敏感度损失的高眼压症患者比例(50%-90%)与临床上将发展为青光眼的高眼压症患者比例(5%-30%)相差甚远。作者研究了这些患者中部分患者的闪烁光敏感度损失并非代表早期青光眼性损害,而是眼内压升高对原本正常眼睛的短暂影响的可能性。在26例高眼压症患者和22例原发性开角型青光眼(POAG)患者进行降压治疗(噻吗洛尔)前后,测量了他们的时间对比敏感度。与血压正常的对照组相比,所有POAG患者在治疗前均表现出敏感度损失,治疗后保持不变。高眼压症患者被分为三组,这可能反映了不同的青光眼转化风险。第一组患者(8/26)闪烁光敏感度正常,因此似乎对高眼压有抵抗力。第二组患者(9/26)最初表现出敏感度损失,随着眼压降低而消失。他们可能尚未遭受损害,但似乎对高眼压敏感。第三组患者(9/26)尽管眼压降低,敏感度损失仍持续存在。他们的反应与POAG患者相似,表明第三组患者已经遭受了早期青光眼性损害。